Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Prostatic Neoplasms × Hormones × Clear all

Phase

Status

Unknown 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Radiosurgery 20 Docetaxel 18 Radiotherapy 15 Androgen Antagonists 14 Leuprolide 11 bicalutamide 9 Goserelin 9 enzalutamide 8 Surveys and Questionnaires 8 Radiotherapy, Intensity-Modulated 7 Prednisone 7 Blood Specimen Collection 7 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 6 Triptorelin Pamoate 6 Multiparametric Magnetic Resonance Imaging 6 Gonadotropin-Releasing Hormone 6 Brachytherapy 6 Abiraterone Acetate 6 abiraterone 4 Standard of Care 4 Positron Emission Tomography Computed Tomography 4 Metformin 4 Heavy Ion Radiotherapy 4 Exercise 4 Estramustine 4 pembrolizumab 3 luprolide acetate gel depot 3 darolutamide 3 cabazitaxel 3 Watchful Waiting 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03432780 2021-01-22

QRT-SOGUG

Spanish Oncology Genito-Urinary Group

Phase 2 Unknown

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡